Heart drug showdown: which works better for kids with enlarged hearts?
NCT ID NCT07197372
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study will compare two heart failure medications—sacubitril/valsartan and captopril—in 70 children aged 1 month to 18 years who have dilated cardiomyopathy (an enlarged, weak heart). The goal is to see which drug improves the heart's pumping ability more over 12 months. Children must be stable for at least 2 weeks before joining and cannot have severe kidney problems or high potassium levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARNI are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.